Organon & Co. (OGN)
13.90
0.00 (0.00%)
USD |
NYSE |
Nov 20, 10:47
Organon Free Cash Flow : 735.00M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 735.00M |
| June 30, 2026 | 558.00M |
| March 31, 2026 | 708.00M |
| December 31, 2025 | 508.00M |
| September 30, 2025 | 598.00M |
| June 30, 2025 | 537.00M |
| March 31, 2025 | 641.00M |
| December 31, 2024 | 693.00M |
| September 30, 2024 | 721.00M |
| June 30, 2024 | 839.00M |
| March 31, 2024 | 510.00M |
| December 31, 2023 | 540.00M |
| Date | Value |
|---|---|
| September 30, 2023 | 548.00M |
| June 30, 2023 | 444.00M |
| March 31, 2023 | 555.00M |
| December 31, 2022 | 555.00M |
| September 30, 2022 | 464.00M |
| June 30, 2022 | 179.00M |
| March 31, 2022 | 1.525B |
| December 31, 2021 | 2.162B |
| September 30, 2021 | 2.193B |
| June 30, 2021 | 2.66B |
| March 31, 2021 | 2.003B |
| December 31, 2020 | 1.932B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Viatris, Inc. | 1.971B |
| Pacira Biosciences, Inc. | 169.00M |
| ANI Pharmaceuticals, Inc. | 199.91M |
| Corcept Therapeutics, Inc. | 194.62M |
| Veru, Inc. | -26.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 370.00M |
| Cash from Investing (Quarterly) | -44.00M |
| Cash from Financing (Quarterly) | -5.00M |
| Free Cash Flow Per Share (Quarterly) | 1.197 |
| Free Cash Flow to Equity (Quarterly) | 325.00M |
| Free Cash Flow to Firm (Quarterly) | 396.10M |
| Free Cash Flow Yield | 20.13% |